Isolated renal cancer specific antigen

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530403, 536 231, C07K 100, C07H 2102

Patent

active

061038733

ABSTRACT:
The invention described methods for identifying a molecule of interest, as well as nucleic acid molecules which encode it, and binding partners for it. A cDNA library from a cell expressing the target is prepared, and expressed in host cells. Lysates of the host cells are screened with a sample, treated to remove interfering binding partners. The treatment involves contact of the sample to lysates of untransfected host cells, and host cells transfected or transformed with the same vector used to make the cDNA library. Also a part of the invention are antigens and cDNA identified using the methodology.

REFERENCES:
patent: 5589579 (1996-12-01), Torczynski et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Isolated renal cancer specific antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isolated renal cancer specific antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated renal cancer specific antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2008118

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.